Combined Use of a Novel Cardioplegic Formula With MPS ® Using the MiECC in Isolated CABG Versus OPCABG

Combined Use of a Novel Cardioplegic Formula With MPS ® Using the MiECC in Isolated CABG Versus OPCABG

A patient group receiving a novel cardioplegic formula with MPS ® (Myocardial protection system) and using the MiECC (Minimal extracorporeal circulation system) when undergoing coronary artery bypass grafting is compared to a retrospective patient group undergoing Off-pump coronary artery bypass grafting.

Inclusion Criteria:

• CABG using MPS® or OPCABG

Exclusion Criteria:

• use of other colloid solution than Cardioplexol ® for MPS®
• other inventions than CABG
• myocardial infarction <7 days before CABG
• patients denial of data use